Jay I. Peters is a prominent inventor based in San Antonio, Texas, recognized for his significant contributions to the field of pharmaceutical innovation. With a robust portfolio of six patents, Peters has focused his research on improving drug delivery methods, specifically targeting pulmonary administration.

Latest Patents

Among his latest patents, Peters has developed innovative methods for creating compositions that facilitate the pulmonary delivery of tacrolimus, an immunosuppressive drug. His first patent describes a rapid-dissolving, high-potency, substantially amorphous nanostructured aggregate that is combined with a stabilizer matrix. This matrix may include a polymeric or non-polymeric surfactant and a polymeric or non-polymeric saccharide. The technology boasts a surface area greater than 5 m²/g as measured by BET analysis and exhibits supersaturation for a minimum of 0.5 hours when mixed with simulated lung fluid. This innovative approach potentially enhances the delivery efficiency of tacrolimus to patients requiring immunosuppression.

Another recent patent further advances this technology, focusing again on the rapid-dissolving, high-potency formulations designed for pulmonary delivery of the same drug. By optimizing the conditions under which these aggregates are stabilized, Peters aims to provide more effective treatment options for patients who rely on these vital medications.

Career Highlights

Jay I. Peters is affiliated with the University of Texas System, where he has dedicated his career to advancing pharmacological research. His innovative mindset and commitment to developing effective delivery systems for complex compounds have made him a valuable asset to his institution and the broader scientific community.

Collaborations

Throughout his career, Peters has collaborated with notable professionals in the field, including Robert O. Williams III and Keith P. Johnston. These partnerships have enhanced his research capabilities and have been instrumental in the successful development of his patented technologies.

Conclusion

Jay I. Peters' contributions to the field of pharmaceutical innovations, particularly in pulmonary drug delivery systems, highlight the importance of research and development in improving patient care. His ongoing work at the University of Texas System promises to continue influencing the landscape of medication delivery and therapeutics. With a strong foundation in science and collaboration, Peters exemplifies the spirit of innovation that drives advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.